Please login to the form below

Not currently logged in

FDA approves new version of diabetes drug

Japanese pharmaceutical company Daiichi Sankyo's diabetes treatment Welchol has been approved in a new formulation by the US Food and Drug Administration

Japanese pharmaceutical company Daiichi Sankyo has received US Food and Drug Administration (FDA) approval for a new formulation of its liquid diabetes drug Welchol that can be mixed with fruit juice and diet sodas.

Welchol was first approved in 2009 and was to be mixed with water. The drug lowers blood sugar in patients diagnosed with type 2 diabetes.

Meanwhile Daiichi Sankyo is replacing its legacy, on-premise customer relationship management (CRM) system with Veeva CRM in the UK. The company will deploy Veeva CRM to all of its commercial teams in the UK.

Cloud-based, Veeva CRM requires no hardware or software to purchase, scale or maintain. In addition, Veeva customers benefit from free, automatic upgrades. Changes can be made to the system without user retraining or additional third-party costs.

26th July 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...